Regulatory changes are also taking place. According to the MHRA 2026 report, about 90% of medical devices in Great Britain have been CE marked. This highlights the importance of understanding how UK and CE routes interact during the transition. The MHRA is also progressing reforms to strengthen medical device oversight and post-market surveillance.
In this blog, we will discuss key UK MDR 2002 requirements for manufacturers placing devices on the Great Britain market. This blog also covers classification, conformity assessment, registration, post-market surveillance, software, cybersecurity, and other essential compliance considerations.
Understanding UK Medical Devices Regulations (UK MDR 2002)
The UK Medical Devices Regulations 2002 (UK MDR 2002) is the major regulation for medical devices in Great Britain. These regulations lay down the requirements that must be fulfilled by manufacturers to launch their devices lawfully in the UK. Areas covered under these regulations include safety, performance, risk management, conformity assessment, technical documentation, and post-market surveillance.
They are currently regulated through the Medicines and Medical Devices Act 2021 and have been revised in light of the present regulatory system in the UK. The post-market surveillance rules became mandatory as well on 16 June 2025.
Manufacturers must meet UK medical device regulations before and after placing a medical device on the Great Britain market. This includes:
Meet safety and performance requirements: Devices must be safe, perform as intended, and have appropriate risk controls. Manufacturers must also maintain supporting technical documentation.
Complete conformity assessment: You should follow the correct conformity assessment route based on the device. Higher-risk devices generally require assessment by a UK Approved Body.
Register devices with the MHRA: You have to register the devices with the MHRA before placing them on the Great Britain market. The requirements apply across different device classes and include IVDs and custom-made devices.
Maintain post-market surveillance: You should monitor to ensure the safety and performance of the devices even after their placement on the market.
Maintain compliance: Respond to new safety information, regulatory changes, and issues identified through post-market monitoring.
source: https://qualysec.com/uk-med ...